TY - JOUR T1 - A general computational framework for COVID-19 modelling with applications to testing varied interventions in education environments JF - medRxiv DO - 10.1101/2021.03.08.21253122 SP - 2021.03.08.21253122 AU - Joshua W. Moore AU - Zechariah Lau AU - Katerina Kaouri AU - Trevor C. Dale AU - Thomas E. Woolley Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/09/17/2021.03.08.21253122.abstract N2 - We construct a spatially-compartmental individual-based model of the spread of Covid-19 in indoor spaces. The model can be used to predict the infection rates in a variety of locations when various non-pharmaceutical interventions (NPIs) are introduced. Tasked by the Welsh Government, we apply the model to secondary schools and Further and Higher Education environments. Specifically, we consider student populations mixing in a classroom and in halls of residence. We focus on assessing the potential efficacy of Lateral Flow Devices (LFDs) when used in broad-based screens for asymptomatic infection or in ‘test-to-release’ scenarios in which individuals who have been exposed to infection are released from isolation given a negative result. LFDs are also compared to other NPIs; we find that, although LFD testing can be used to mitigate the spread of Covid-19, it is more effective to invest in personal protective equipment, e.g. masks, and in increasing ventilation quality. In addition, we provide an open-access and user-friendly online applet that simulates the individual-based model, complete with user tutorials to encourage the use of the model to aid educational policy decisions as input infection data evolves (https://bit.ly/CV19_INTER_IBM).Competing Interest StatementThe authors have declared no competing interest.Funding StatementJWM is supported by Knowledge Economy Skills Scholarships (KESS2) a pan-Wales higher-level skills initiative led by Bangor University on behalf of the Higher Education sector in Wales. It is part-funded by the Welsh Government′s European Social Fund (ESF). JWM also received support from Just One Giant Lab (JOGL) (Grant No: 520772).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo clinical data was produced in this study. We provide an open-access repository for the code and test files required to run the model outlined in the present study. https://github.com/joshwillmoore1/COVID-19_Intervention_IBM ER -